Today’s Solutions: July 25, 2024

Since the start of the coronavirus outbreak, scientists have been ceaselessly looking for ways to fight back. And while much attention has focused on the development of a vaccine, researchers have also been looking at using antibodies from recovered patients to unlock new treatments for COVID-19.

Typically the antibodies can be obtained from patients who have recovered from the virus — llamas included — but since it would take forever to get enough samples this way, a group of researchers is taking a more efficient approach to mass-producing the antibodies — cloning.

Doctors and medical researchers from Mount Sinai Health System and the pharmaceutical company Sorrento Therapeutics have partnered up to clone those protective antibodies and use them to mass-produce what they’re calling a “pharmaceutical cocktail.”

When administered to a naïve — or a yet-uninfected — person, those antibodies could help bolster their immune systems against the coronavirus, similarly to how a vaccine would work. They also hope it could help patients who caught the coronavirus but haven’t quite fought it off yet.

Compared to a vaccine, which takes time to generate immunity and may not trigger a response in some people, the yet-undeveloped treatment is expected to protect patients for as much as two months straight — and could help protect more people than a vaccine would.

After studying blood samples from about 15,000 recovered, the researchers hope to identify which antibodies offer the strongest protection against the coronavirus and clone them en masse. The plan is to also include three different antibodies to ensure the therapy is resistant to future virus mutations.

Researchers expect to begin clinical trials on both sick and uninfected patients in the coming months. If all goes well, the experimental therapy is expected to be available by the end of the year.

Solutions News Source Print this article
More of Today's Solutions

Ecuador’s historic court ruling grants Quito’s Machángara river t...

BY THE OPTIMIST DAILY EDITORIAL TEAM On July 7th, an Ecuadorian court ruled that pollution violates the rights of the Machángara River, which flows ...

Read More

Don’t feed bread to ducks! Here’s what to serve instead

BY THE OPTIMIST DAILY EDITORIAL TEAM When venturing out into the Great Outdoors, it’s important never to feed the wildlife because they can become ...

Read More

These bladeless wind turbines could revolutionize the renewable sector

Bladeless wind turbines may sound counterintuitive, but a new startup aims to prove that these devices could reinvent the way we harness wind power ...

Read More

Revel at the most detailed image of our universe yet

Here at The Optimist Daily, we have been sharing every exciting step of the James Webb Telescope’s journey, from its long-awaited launch, to when ...

Read More